Newsletter November 2023 (2/2)
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
 
VIEW IN BROWSER
 
 
SCIENA Header
ETH Domain News
November 30, 2023
 
 
 
Climate change and… winter sports
Climate change and… winter sports
With climate change resulting in less natural snow and higher temperatures, challenging times lie ahead for tourist destinations that depend on winter sports, as well as for winter sports fans. Artificial snow and snow farming can help, but even these have their limitations.

Read more...
 
 
 
Arzt und KI © iStock 2023
EPFL's new Large Language Model for Medical Knowledge
EPFL researchers have just released Meditron, the world’s best performing open source Large Language Model tailored to the medical field designed to help guide clinical decision-making.

Read more...
 
Quagga mussels in Lake Geneva: the biomass per square metre is likely to increase by a factor of nine to 20 over the next 22 years. (Photo: Eawag, Linda Haltiner).
Quagga mussel: prognosis for affected lakes
A comparison of three Swiss lakes with the Great Lakes of North America show for the first time that the invasive quagga mussel is spreading on both continents with a similar dynamic. This gives Europe a glimpse into the future.

Read more...
 
 
 
 
Twitter
 
 
 
Artificial intelligence is helping in the search for active ingredients for tomorrow's medicines. Image: AI generated with Midjourney. (Visualisation: ETH Zurich)
Artificial intelligence finds ways to develop new drugs
A new AI model developed by chemists at ETH Zurich can not only predict where a pharmaceutically active molecule can be chemically modified, but also how best to do it. This makes it possible to identify new pharmaceutical ingredients more quickly and improve existing ones in a targeted manner.

Read more...
 
Cerebral tumor (glioma) of a mouse - 2023 EPFL / Michele De Palma - CC-BY-SA 4.0
Treating tumors with engineered dendritic cells
Cancer biologists at EPFL, UNIGE, and the German Cancer Research Center (Heidelberg) have developed a novel immunotherapy that does not require knowledge of a tumor’s antigenic makeup. The new results may pave the way to first-in-kind clinical applications.

Read more...
 
 
 
 
Video
 
 
 
Youtube Printscreen
Autonomous excavator constructs a six-metre-high dry stone wall
🕒 1 minute

Watch the video...
 
 
 
About Sciena
 
 
Unsubscribe About Sciena Privacy Policy
Copyright © 2023 ETH-Rat, Bern / Zurich                 
Follow us